On the other hand, fructose-1,6-bisphosphatase (FBPase) expression was upregulated in the NASH model, but no change was observed in silibinin-treated mice, just like the ND mice (Table 1). Here, FBP1 is linked to metabolic dysfunction-associated steatohepatitis.